The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia.
Détails
ID Serval
serval:BIB_DBECCA1A0EFD
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia.
Périodique
Clinical infectious diseases
ISSN
1537-6591 (Electronic)
ISSN-L
1058-4838
Statut éditorial
Publié
Date de publication
15/08/2016
Peer-reviewed
Oui
Volume
63 Suppl 2
Pages
S46-51
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Publication Status: ppublish
Résumé
The Innovative Medicines Initiative-funded COMBACTE consortium fosters academic-industry partnership in pioneering studies to combat serious bacterial infections. We describe how this partnership is advancing the development of 2 monoclonal antibodies, MEDI4893 and MEDI3902, for the prevention of nosocomial pneumonia.
Mots-clé
Anti-Bacterial Agents/therapeutic use, Antibodies, Monoclonal/therapeutic use, Cross Infection/prevention & control, Drug Discovery, Humans, Pneumonia, Bacterial/prevention & control, Pneumonia, Ventilator-Associated/prevention & control, Public-Private Sector Partnerships, United States, ICU, monoclonal antibody, nosocomial pneumonia, ventilator-associated pneumonia
Pubmed
Web of science
Open Access
Oui
Création de la notice
04/08/2016 16:57
Dernière modification de la notice
21/08/2019 5:36
Données d'usage
